120 related articles for article (PubMed ID: 7646990)
1. Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis.
Larcher C; Fend F; Mitterer M; Prang N; Schwarzmann F; Huemer HP
Br J Haematol; 1995 Jul; 90(3):532-40. PubMed ID: 7646990
[TBL] [Abstract][Full Text] [Related]
2. Chronic active Epstein-Barr virus disease in a case of persistent polyclonal B-cell lymphocytosis.
Mitterer M; Pescosta N; Fend F; Larcher C; Prang N; Schwarzmann F; Coser P; Huemer HP
Br J Haematol; 1995 Jul; 90(3):526-31. PubMed ID: 7646989
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene.
Larcher C; McQuain C; Berger C; Mitterer M; Quesenberry PJ; Huemer HP; Knecht H
Ann Hematol; 1997 Jan; 74(1):23-8. PubMed ID: 9031611
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of chronic Epstein-Barr virus infection: detection of a virus strain with a high rate of lytic replication.
Jäger M; Prang N; Mitterer M; Larcher C; Huemer HP; Reischl U; Wolf H; Schwarzmann F
Br J Haematol; 1996 Dec; 95(4):626-36. PubMed ID: 8982037
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus.
Selves J; Meggetto F; Brousset P; Voigt JJ; Pradère B; Grasset D; Icart J; Mariamé B; Knecht H; Delsol G
Am J Surg Pathol; 1996 Jun; 20(6):747-53. PubMed ID: 8651355
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection in sarcomatoid renal cell carcinoma tissues.
Kim KH; Han EM; Lee ES; Park HS; Kim I; Kim YS
BJU Int; 2005 Sep; 96(4):547-52. PubMed ID: 16104908
[TBL] [Abstract][Full Text] [Related]
8. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
[TBL] [Abstract][Full Text] [Related]
10. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
11. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
[TBL] [Abstract][Full Text] [Related]
12. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
13. Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridization.
Chow KC; Nacilla JQ; Witzig TE; Li CY
Am J Hematol; 1992 Dec; 41(4):270-5. PubMed ID: 1337664
[TBL] [Abstract][Full Text] [Related]
14. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome.
Hosoi H; Imadome KI; Tamura S; Kuriyama K; Murata S; Yamashita Y; Mushino T; Oiwa T; Kobata H; Nishikawa A; Nakakuma H; Hanaoka N; Isobe Y; Ohshima K; Sonoki T
Leuk Res; 2017 Apr; 55():1-5. PubMed ID: 28110206
[TBL] [Abstract][Full Text] [Related]
15. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
Peng M; Lundgren E
Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
[TBL] [Abstract][Full Text] [Related]
16. Functional T-cell anergy in a case of persistent polyclonal B-cell lymphocytosis.
Mitterer M; Lanthaler AJ; Irschick EU; Engelmann H; Larcher C; Huemer HP
Leuk Res; 2005 Dec; 29(12):1479-88. PubMed ID: 15979703
[TBL] [Abstract][Full Text] [Related]
17. Combined automated cell and flow cytometric analysis enables recognition of persistent polyclonal B-cell lymphocytosis (PPBL), a study of 25 patients.
Schmidt-Hieber M; Burmeister T; Weimann A; Nagorsen D; Hofmann WK; Thiel E; Schwartz S
Ann Hematol; 2008 Oct; 87(10):829-36. PubMed ID: 18587574
[TBL] [Abstract][Full Text] [Related]
18. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
[TBL] [Abstract][Full Text] [Related]
19. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
[TBL] [Abstract][Full Text] [Related]
20. Activation of human thymocytes after infection by EBV.
Paterson RL; Kelleher CA; Streib JE; Amankonah TD; Xu JW; Jones JF; Gelfand EW
J Immunol; 1995 Feb; 154(3):1440-9. PubMed ID: 7822809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
